Kopran Ltd.
| BSE: 524280 | Sector: Health care |
| NSE: KOPRAN | ISIN Code: INE082A01010 |
| BSE 00:00 | 24 Sep | 205.55 |
-4.25 (-2.03%) |
OPEN
212.00 |
HIGH
212.00 |
LOW
205.00 |
| NSE 00:00 | 24 Sep | 205.75 |
-2.85 (-1.37%) |
OPEN
212.00 |
HIGH
212.90 |
LOW
205.05 |
| OPEN | 212.00 |
| PREVIOUS CLOSE | 209.80 |
| VOLUME | 8575 |
| 52-Week high | 262.00 |
| 52-Week low | 79.10 |
| P/E | 48.48 |
| Mkt Cap.(Rs cr) | 889 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kopran Ltd. (KOPRAN) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 722.10 | -11.50 | -1.57 | 3112.91 |
| Cipla | 967.00 | -1.05 | -0.11 | 2468.28 |
| Dr Reddy's Labs | 4792.80 | -3.20 | -0.07 | 2186.40 |
| Sun Pharma.Inds. | 769.70 | -0.05 | -0.01 | 2139.70 |
| Divi's Lab. | 5101.80 | -111.05 | -2.13 | 1954.72 |
| Alkem Lab | 4001.85 | 37.65 | 0.95 | 1685.08 |
| Glenmark Pharma. | 507.65 | -4.45 | -0.87 | 1649.45 |
| Cadila Health. | 564.75 | -2.15 | -0.38 | 1476.20 |
| Lupin | 926.20 | -14.20 | -1.51 | 1258.62 |
| Alembic Pharma | 791.75 | -28.15 | -3.43 | 1175.39 |
| Ipca Labs. | 2402.10 | -73.45 | -2.97 | 1140.77 |
| Torrent Pharma. | 3100.25 | -1.95 | -0.06 | 1137.85 |
| Gland Pharma | 3847.40 | -62.70 | -1.60 | 997.01 |
| Laurus Labs | 609.80 | -12.15 | -1.95 | 956.11 |
| Abbott India | 21189.15 | -399.30 | -1.85 | 690.69 |
| Ajanta Pharma | 2173.00 | -10.80 | -0.49 | 675.64 |
| Wockhardt | 425.30 | -7.60 | -1.76 | 593.29 |
| Granules India | 321.45 | 0.00 | 0.00 | 552.78 |
| Pfizer | 5704.90 | -116.40 | -2.00 | 497.61 |
| Sanofi India | 8079.05 | -119.70 | -1.46 | 477.60 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
